CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Assessing impact of COVID19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug2249 Prone position Wiki 0.58

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.09
D012128 Respiratory Distress Syndrome, Adult NIH 0.08
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Impact of COVID-19 on Marshallese Communities in the U.S.

Up to 2000 Marshallese will complete an online or telephone survey. Among those who complete the survey, 40 participants will be randomly selected and invited to complete an in-depth qualitative interview. This survey will collect data describing the impact of COVID-19 on self-reported Marshallese persons in the United States. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to implementing preventative recommendations, 4) barriers and facilitators to COVID-19 testing when appropriate, and self-care behaviors during COVID-19.

NCT04474496 COVID-19 Other: Assessing impact of COVID19

Primary Outcomes

Description: Respondents will be asked how COVID-19 has impacted mulitple facets of their lives, including housing, food security, and employment and income

Measure: Effects of COVID-19 on social determinants of health

Time: Baseline

Secondary Outcomes

Description: Respondents will be asked to rate their general health and mental health now and compared with before the COVID-19 outbreak

Measure: Effects of COVID-19 on general health status and mental health

Time: Baseline

Description: Respondents with type 2 diabetes will be asked to compare their current self-care behaviors with before the COVID-19 outbreak using multiple items, including the Summary of Diabetes Self-Care Activities (adapted to include retrospective pre-COVID-19 comparisons of behaviors)

Measure: Effects of COVID-19 on disease management

Time: Baseline

Description: Using Behavioral Risk Factor Surveillance System items and relevant items from the Summary of Diabetes Self-Care Activities, respondents will be asked to compare their current diet and physical activity behaviors with before the COVID-19 outbreak

Measure: Effects of COVID-19 on diet and physical activity behaviors

Time: Baseline

Description: Respondents will be asked to report whether they have been screened for COVID-19 (and how), whether they have been tested for COVID-19 (and how), whether they would accept a COVID-19 vaccine, and what specific actions they have taken to prevent being infected by COVID-19

Measure: COVID-19 screening, testing, and prevention

Time: Baseline

Description: Respondents will be asked to report which sources of information they use the most and trust the most to stay informed about COVID-19

Measure: Trusted sources of COVID-19 information

Time: Baseline

Description: Respondents will be asked to report how the COVID-19 outbreak has impacted their daily lives, including health concerns, impacts on family, and access to healthcare

Measure: Impacts of COVID-19 on daily life

Time: Baseline

Description: Respondents will be asked to report how likely they feel they are to be infected, their chances of dying if infected, how easy it is to avoid being infected, and how concerned they are with what could result from being infected (e.g., losing a job, infecting others, being isolated)

Measure: COVID-19 attitudes, fears, and beliefs

Time: Baseline

No related HPO nodes (Using clinical trials)